Medicis Suit Claims Aurobindo Infringes U.S. Patents for Solodyn Acne Drug

Medicis Pharmaceutical Corp. sued Indian rival Aurobindo Pharma Ltd. in federal court in Delaware, seeking to block a generic form of the acne medicine Solodyn and alleging infringement of two U.S. patents.

To contact the reporter on this story: Phil Milford in Wilmington at pmilford@bloomberg.net

To contact the editor responsible for this story: Fred Strasser at fstrasser@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.